1. Hindricks, G, Potpara, T, Dagres, N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the Europe. Eur Heart J. 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612
Google Scholar | Crossref | Medline2. Krijthe, BP, Kunst, A, Benjamin, EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746-2751. doi:10.1093/eurheartj/eht280
Google Scholar | Crossref | Medline3. Miyasaka, Y, Barnes, ME, Gersh, BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119-125. doi:10.1161/CIRCULATIONAHA.105.595140
Google Scholar | Crossref | Medline | ISI4. Colilla, S, Crow, A, Petkun, W, Singer, DE, Simon, T, Liu, X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142-1147. doi:10.1016/j.amjcard.2013.05.063
Google Scholar | Crossref | Medline | ISI5. Kirchhof, P, Benussi, S, Kotecha, D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38). doi:10.1093/eurheartj/ehw210
Google Scholar | Crossref6. Weber, C, Hung, J, Hickling, S, Li, I, McQuillan, B, Briffa, T. Drivers of hospitalisation trends for non-valvular atrial fibrillation in Western Australia, 2000-2013. Int J Cardiol. 2019;276:273-277. doi:10.1016/j.ijcard.2018.09.047
Google Scholar | Crossref | Medline7. Patel, NJ, Deshmukh, A, Pant, S, et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014;129(23):2371-2379. doi:10.1161/CIRCULATIONAHA.114.008201
Google Scholar | Crossref | Medline8. Friberg, L, Hammar, N, Pettersson, H, Rosenqvist, M. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J. 2007;28(19):2346-2353. doi:10.1093/eurheartj/ehm308
Google Scholar | Crossref | Medline | ISI9. Keating, RJ, Gersh, BJ, Hodge, DO, et al. Effect of atrial fibrillation pattern on survival in a community-based cohort. Am J Cardiol. 2005;96(10):1420-1424. doi:10.1016/j.amjcard.2005.07.050
Google Scholar | Crossref | Medline10. Tzikas, A, Samaras, A, Kartas, A, et al. Motivational Interviewing to Support Oral AntiCoagulation Adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial. Eur Heart J Cardiovasc Pharmacother. 2021;7(FI1): f63-f71. doi:10.1093/ehjcvp/pvaa039
Google Scholar | Crossref | Medline11. Samaras, A, Kartas, A, Vasdeki, D, et al. Rationale and design of a randomized study comparing Motivational Interviewing to Support Oral AntiCoagulation Adherence versus usual care in patients with non-valvular Atrial Fibrillation: the MISOAC-AF trial. Hellenic J Cardiol. 2020;61(6):453-454. doi:10.1016/j.hjc.2020.02.007
Google Scholar | Crossref | Medline12. World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053
Google Scholar | Crossref | Medline | ISI13. Leung, M, van Rosendael, PJ, Abou, R, et al. The impact of atrial fibrillation clinical subtype on mortality. JACC Clin Electrophysiol. 2018;4(2):221-227. doi:10.1016/j.jacep.2017.09.002
Google Scholar | Crossref | Medline14. Link, MS, Giugliano, RP, Ruff, CT, et al. Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ Arrhythmia Electrophysiol. 2017;10(1):1-8. doi:10.1161/CIRCEP.116.004267
Google Scholar | Crossref15. Ganesan, AN, Chew, DP, Hartshorne, T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591-1602. doi:10.1093/eurheartj/ehw007
Google Scholar | Crossref | Medline16. Stöllberger, C, Winkler-Dworak, M, Finsterer, J, Hartl, E, Chnupa, P. Factors influencing mortality in atrial fibrillation. Post hoc analysis of an observational study in outpatients. Int J Cardiol. 2005;103(2):140-144. doi:10.1016/j.ijcard.2004.08.036
Google Scholar | Crossref | Medline17. Atar, D, Berge, E, Le Heuzey, J-Y, et al. The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events. Europace. 2020;22(2):195-204. doi:10.1093/europace/euz292
Google Scholar | Crossref | Medline18. Pak, HN, Hwang, C, Hong, EL, Jin, WK, Hyun, SL, Kim, YH. Electroanatomic characteristics of atrial premature beats triggering atrial fibrillation in patients with persistent versus paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17(8):818-824. doi:10.1111/j.1540-8167.2006.00503.x
Google Scholar | Crossref | Medline19. Zrenner, B, Ndrepepa, G, Karch, MR, et al. Electrophysiologic characteristics of paroxysmal and chronic atrial fibrillation in human right atrium. J Am Coll Cardiol. 2001;38(4):1143-1149. doi:10.1016/s0735-1097(01)01493-0
Google Scholar | Crossref | Medline20. Chen, LY, Chung, MK, Allen, LA, et al. Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association. Circulation. 2018;137(20):e623-e644. doi:10.1161/CIR.0000000000000568
Google Scholar | Crossref | Medline21. Proietti, M, Laroche, C, Opolski, G, Maggioni, AP, Boriani, G, Lip, GYH. ‘Real-world’ atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation general registry pilot phase. Europace. 2017;19(5):722-733. doi:10.1093/europace/euw112
Google Scholar | Medline22. Schroder, J, Bouaziz, O, Agner, BR, et al. Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation. PLoS One. 2019;14(6):1-12. doi:10.1371/journal.pone.0217983
Google Scholar | Crossref23. Le Heuzey, JY, Paziaud, O, Piot, O, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J. 2004;147(1):121-126. doi:10.1016/S0002-8703(03)00524-6
Google Scholar | Crossref | Medline | ISI24. Stewart, S, Murphy, N, Walker, A, McGuire, A, McMurray, JJV. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004;90(3):286-292. doi:10.1136/hrt.2002.008748
Google Scholar | Crossref | Medline | ISI25. Amin, AN, Jhaveri, M, Lin, J. Hospital readmissions in US atrial fibrillation patients: occurrence and costs. Am J Ther. 2013;20(2):143-150. doi:10.1097/MJT.0b013e3182512c7e
Google Scholar | Crossref | Medline26. Friberg, L, Hammar, N, Rosenqvist, M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31(8):967-975. doi:10.1093/eurheartj/ehn599
Google Scholar | Crossref | Medline27. Hart, RG, Pearce, LA, Rothbart, RM, McAnulty, JH, Asinger, RW, Halperin, JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol. 2000;35(1):183-187. doi:10.1016/S0735-1097(99)00489-1
Google Scholar | Crossref | Medline28. Hohnloser, SH, Pajitnev, D, Pogue, J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy. An ACTIVE W substudy. J Am Coll Cardiol. 2007;50(22):2156-2161. doi:10.1016/j.jacc.2007.07.076
Google Scholar | Crossref | Medline29. Botto, GL, Tortora, G, Casale, MC, Canevese, FL, Maria Brasca, FA. Impact of the pattern of atrial fibrillation on stroke risk and mortality. Arrhythmia Electrophysiol Rev. 2021;10(2):68-76. doi:10.15420/aer.2021.01
Google Scholar | Crossref | Medline30. Hohnloser, SH, Vamos, M. Not all types of atrial fibrillation carry the same stroke risk, but most benefit from oral anticoagulation. Circ Arrhythmia Electrophysiol. 2017;10(1):3-5. doi:10.1161/CIRCEP.116.004847
Google Scholar | Crossref